Literature DB >> 20096993

Functional results following vescica ileale Padovana (VIP) neobladder: midterm follow-up analysis with validated questionnaires.

Giacomo Novara1, Vincenzo Ficarra, Anila Minja, Vincenzo De Marco, Walter Artibani.   

Abstract

BACKGROUND: Orthotopic bladder reconstruction is the preferred method of urinary diversion following radical cystectomy (RC). Several papers reported functional data of different orthotopic neobladders, although to date, no one has used validated questionnaires.
OBJECTIVE: To evaluate the midterm functional results in a contemporary series of patients undergoing RC and vescica ileale Padovana (VIP) orthotopic neobladder by applying a set of validated questionnaires. DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional study at a single academic centre. INTERVENTION: We included RC and VIP orthotopic techniques for bladder transitional cell carcinoma. MEASUREMENTS: The American Urological Association Symptom Index (AUA-SI), the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF), and the five-item version of the International Index of Erectile Function (IIEF-5) were used to evaluate functional outcomes. RESULTS AND LIMITATIONS: All 113 patients who were alive and disease free at 44-mo follow-up were evaluated. Sixteen patients (13%) were on clean intermittent catheterisation (CIC). The median AUA-SI score of the 97 voiding patients was 9 (interquartile range [IQR]: 4.5-16). Specifically, 48.5%, 40.2%, and 11.3% of the patients had mild, moderate, or severe lower urinary tract symptoms (LUTS), respectively. American Society of Anaesthesiologists class (odds ratio [OR]: 9.0; p=0.03) and body mass index (OR: 1.5; p=0.023) were independent predictors of the need for CIC, while only patient age at the time of surgery (OR: 0.920; p=0.01) was predictive of LUTS severity. The median ICIQ-UI SF score was 6 (IQR: 3-10). Twenty patients (17.7%) were fully continent, while 31.9%, 35.4%, and 15% had slight, moderate, and severe incontinence, respectively. About 90% of the patients during the day and 80% during the night used no pad or only a safety pad. Most of the patients leaked when asleep. No variable was predictive of return to continence. Finally, roughly 20% of the male patients were potent, having an IIEF-5 score ≥17.
CONCLUSIONS: We reported midterm functional outcomes following RC and VIP neobladder using validated questionnaires. On the whole, the results are encouraging. However, in the absence of patient self-completed questionnaires, functional outcomes may be significantly overestimated.
Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20096993     DOI: 10.1016/j.eururo.2010.01.007

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  15 in total

1.  [Management of urinary incontinence after orthotopic urinary diversion].

Authors:  A Soave; R Dahlem; M Rink; S Ahyai; M Fisch
Journal:  Urologe A       Date:  2012-04       Impact factor: 0.639

Review 2.  [Treatment of bladder cancer. Value of radical prostate-sparing cystectomy].

Authors:  A Heidenreich; D Porres; D Pfister
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

3.  Perugia ileal neobladder: functional results and complications.

Authors:  Massimo Porena; Luigi Mearini; Alessandro Zucchi; Michele Del Zingaro; Ettore Mearini; Antonella Giannantoni
Journal:  World J Urol       Date:  2012-11-13       Impact factor: 4.226

Review 4.  Updates on Robotic Intracorporeal Urinary Diversions.

Authors:  Shawn Dason; Alvin C Goh
Journal:  Curr Urol Rep       Date:  2018-03-15       Impact factor: 3.092

5.  Symptom Severity and Quality of Life Among Long-term Colorectal Cancer Survivors Compared With Matched Control Subjects: A Population-Based Study.

Authors:  Tae L Hart; Susan T Charles; Mekhala Gunaratne; Nancy N Baxter; Michelle Cotterchio; Zane Cohen; Steven Gallinger
Journal:  Dis Colon Rectum       Date:  2018-03       Impact factor: 4.585

6.  Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction.

Authors:  Ameeta L Nayak; Ilias Cagiannos; Luke T Lavallée; Chris Morash; Duane Hickling; Ranjeeta Mallick; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

7.  Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study.

Authors:  E Pons-Tostivint; M Roumiguié; V Tostivint; G Verhoest; B Cabarrou; J Gas; P Coloby; J Zgheib; M Thoulouzan; M Soulié; X Gamé; J B Beauval
Journal:  World J Urol       Date:  2020-10-16       Impact factor: 4.226

Review 8.  Orthotopic neobladder reconstruction.

Authors:  Dwayne T S Chang; Nathan Lawrentschuk
Journal:  Urol Ann       Date:  2015 Jan-Mar

9.  Incidental prostate cancer at the time of cystectomy: the incidence and clinicopathological features in Chinese patients.

Authors:  Jiahua Pan; Wei Xue; Jianjun Sha; Hu Yang; Fan Xu; Hanqing Xuan; Dong Li; Yiran Huang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Comparison Between Ambulatory and Conventional Urodynamics of the Modified Orthotopic Hautmann Neobladder.

Authors:  Malioris Apostolos; Dimitriadis Georgios; Kampantais Spyridon; Gkotsos Georgios; Vakalopoulos Ioannis; Ioannidis Stavros; Hatzimoutatidis Konstantinos; Hatzichristou Dimitrios
Journal:  Int Neurourol J       Date:  2015-12-28       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.